newsfilter
← Latest News
GlobeNewswire·

Zevra Therapeutics Announces Details for Q4 and Full Year 2025 Financial Results Call

CELEBRATION, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today